Drug-labels.com

Fycompa: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
2 mg, 4.0 mg, 6.0 mg, 8.0 mg, 10.0 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Fycompa

What is FYCOMPA used for?

FYCOMPA is used with other medicines to manage:

  • a type of seizure called partial-onset seizures in children 7 years of age and older and adults.

  • a type of seizure called tonic-clonic (grand mal) seizures in children 12 years of age and older and adults who have epilepsy.

FYCOMPA should only be used in patients whose seizures are not controlled with standard treatment.

Serious Warnings and Precautions

FYCOMPA can cause serious or life-threatening mental health and behavioural problems including:
  • aggression
  • hostility
  • irritability
  • anger
  • thoughts of harming or threatening others
  • unusual changes in mood, personality, or behaviour

This can happen even in if you/your child have no history of mental health or behavioural problems.

You/your child, your/their caregiver and family must tell your/your child’s healthcare provider right away if you/your child have any new or unusual changes in mood, personality or behaviour while taking FYCOMPA or after you/your child stop taking it. Your/your child’s healthcare professional may lower your/their dose or have you/them stop taking FYCOMPA.

You/your child should not drink alcohol while taking FYCOMPA. Drinking alcohol while on FYCOMPA can cause your/their mood to worsen or increase your/their anger. Talk to your/your child’s healthcare professional about your/your child’s alcohol consumption and if you/your child have a history or alcohol dependence.

How does FYCOMPA work?

FYCOMPA belongs to a group of medicines called antiepileptic medicines. The exact mechanism of action is not entirely understood.

What are the ingredients in FYCOMPA?

Medicinal ingredient: Perampanel

Non-medicinal ingredients: hypromellose, lactose monohydrate, low substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, talc, and titanium dioxide.

The tablets also contain the following non-medicinal ingredients:

2 mg tablets: yellow ferric oxide, red ferric oxide

4 mg tablets: red ferric oxide

6 mg tablets: red ferric oxide

8 mg tablets: black ferric oxide, red ferric oxide

10 mg tablets: FD&C Blue #2 indigo carmine aluminum lake, yellow ferric oxide

12 mg tablets: FD&C Blue #2 indigo carmine aluminum lake

FYCOMPA comes in the following dosage forms:

Tablets: 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg

Do not use FYCOMPA if:

  • you/your child are allergic to perampanel or any of the other ingredients in FYCOMPA.

To help avoid side effects and ensure proper use, talk to you/your child’s healthcare professional before you/your child take FYCOMPA. Talk about any health conditions or problems you/your child may have, including if you/your child:

  • Have or have had depression, mood problems, or suicidal thoughts or behaviour.
  • Have mild or moderate liver problems.
  • Have moderate or severe kidney problems or are undergoing hemodialysis.
  • Have or ever had a problem with:

    • substance use, including prescribed or illegal drugs, or
    • alcohol

  • Are taking birth control, especially birth control containing levonorgestrel. FYCOMPA may decrease the efficacy of birth control that contains levonorgestrel.
  • Are pregnant or plan to become pregnant.
  • Are breastfeeding or plan to breastfeed.
  • Are taking other antiepileptic medicines such as carbamazepine, oxcarbazepine, and phenytoin
  • Are lactose intolerant or have one of the following rare hereditary disease:

    • galactose intolerance
    • Lapp lactase deficiency
    • glucose-galactose malabsorption
  • Regularly or occasionally drink alcohol.
  • Are 65 years of age or older.

Other warnings you should know about:

Do not stop your/your child’s treatment with FYCOMPA without first checking with your/your child’s healthcare professional. This could lead to a sudden worsening of your/your child’s seizures or make them happen more often.

Severe skin reactions: Serious allergic reactions, such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), can be caused by anti-seizure medicines, often involving a skin reaction. These may occur shortly after starting treatment, or several months later. Get help right away if you/your child develop a skin rash, regardless of its severity, either alone or with a combination of the following symptoms:

  • any other serious skin reaction such as blistering or peeling of the mouth, nose, eyes or genitals,
  • fever,
  • swollen glands,
  • flu-like feeling,
  • swelling of the face and/or legs,
  • problems related to the liver, kidneys, heart, lungs or other organs

Driving and Using Machines: FYCOMPA may make you/your child feel dizzy, drowsy and affect your/their coordination. These effects may be worse if you/your child drink alcohol. Do not drive, use machinery, or do activities that require you/your child to be alert until you/they know how FYCOMPA affects you/them.

Falls and Injuries: FYCOMPA may cause you/your child to feel sleepy, dizzy and affect your/your child’s balance and coordination. This increases the risks of falling, which can cause fractures or other fall-related injuries, especially when there is a change in your/your child’s dose, or you are elderly.

Suicidal thoughts and behaviour: FYCOMPA may cause you/your child to have suicidal thoughts and behaviours or to become more depressed. If you/your child have thoughts of harming or killing yourself/themselves or others at any time, tell your/their healthcare professional or go to a hospital right away. You/your child may find it helpful to tell a relative or close friend you/your child are taking FYCOMPA. Ask them to read this leaflet. You might ask them to tell you if they:

  • think your/your child’s depression is getting worse, or
  • are worried about changes in your/your child’s behaviour.

Pregnancy and breastfeeding:

  • It is not known if FYCOMPA can harm your/your child’s unborn baby. Tell your/your child’s

    • healthcare professional right away if you/your child become pregnant or think you/your child might be pregnant while taking FYCOMPA. You and your/your child’s healthcare professional will decide if you/your child should take FYCOMPA while you/your child are pregnant.
  • Pregnancy registry: If you/your child become pregnant while taking FYCOMPA, talk to your/your child’s healthcare professional about registering with the North American Antiepileptic Drug Pregnancy Registry. You/your child can enroll in this registry by calling 1-888-233-2334. The purpose of this registry is to collect information about the safety of antiepileptic medicines during pregnancy. Information about the registry can also be found at the website: http://www.aedpregnancyregistry.org/.
  • It is not known whether FYCOMPA can pass into breast milk. You must discuss with your/your child’s healthcare professional whether to breastfeed or take FYCOMPA.

Vision Problems: FYCOMPA may cause you/your child to see two of the same image (diplopia) or blurred vision. If you/your child experience problems with your/their vision while taking FYCOMPA, talk to your/your child’s healthcare professional.

Tell your/your child’s healthcare professional about all the medicines you/your child take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with FYCOMPA:

  • other antiepileptic drugs such as carbamazepine, phenytoin, oxcarbazepine, phenobarbital, lamotrigine, topiramate, clobazam, and valproic acid
  • alcohol
  • birth control containing levonorgestrel
  • medicines used to treat HIV
  • medicines used to treat bacterial infections such as rifampin and clarithromycin
  • St. John’s Wort, a herbal remedy
  • medicines used to treat fungal infections such as ketoconazole
  • midazolam, used before surgery and other medical procedures to cause drowsiness and decrease anxiety
  • central nervous system depressants including benzodiazepines, narcotics, barbituates and sedating antihistamines
  • levodopa, used to treat symptoms of Parkinson’s disease

How to take FYCOMPA:

  • Take/give FYCOMPA exactly as your/your child’s healthcare professionals tell you to. They will decide on the dose that is right for you/your child. Never increase or decrease your/your child’s dose without talking to your/their healthcare professional.
  • Do not stop taking/giving FYCOMPA without talking to your/your child’s healthcare professional. Stopping FYCOMPA suddenly can cause your/your child’s seizures to be worse or make them happen more often. Your/your child’s healthcare professional will tell you if and when you/your child can stop taking this medicine.
  • Take/give your/your child’s dose once a day at bedtime.

Usual dose:

Usual starting dose: Your/your child’s healthcare professional will determine the starting dose that is right for you/your child. This may be 2 mg or 4 mg once a day. Your/their dose will depend on:

  • if you/they have liver or kidney problems
  • other antiepileptic medicines you/your child may be taking

Depending on your/your child’s response and tolerability to FYCOMPA, your/your child’s healthcare professional may increase your/your child’s dose.

Maximum daily dose: 12 mg a day

Overdose:

Signs of an overdose may include:

  • changes to mental status
  • agitation
  • aggressive behaviour
  • dizziness
If you think you, or a person you are caring for, have taken too much FYCOMPA, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you/your child miss a dose of this medication, do not make up the missed dose. Skip the missed dose and continue with your/their next scheduled dose. Do not take or give two doses at the same time to make up for the missed dose.

Talk to your/your child’s healthcare professional if you/your child miss more than one dose.

What are possible side effects from using FYCOMPA?

These are not all the possible side effects you/your child may have when taking FYCOMPA. If you/your child experience any side effects not listed here, tell your/their healthcare professional.

Side effects may include:

  • dizziness
  • sleepiness
  • tiredness
  • problems with muscle coordination
  • problems with walking normally (gait disturbance)
  • vertigo (sense of spinning)
  • weight gain
  • nausea
  • diarrhea
  • vomiting
  • joint pain
  • muscle aches and pain
  • feeling weak or lacking of energy
  • cough, runny nose, fever, sore throat
  • constipation
  • headache

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Irritability✓
Fall✓
Vision Problems: seeing two of the same image (diplopia), blurred vision✓
RARE

Suicidal thoughts or

actions changes: unusual

behaviours, depression,

worsening of depression,

leading to thoughts of self-harm or suicide

✓
Extreme sleepiness or tiredness and/or difficulty coordinating muscles normally✓
Mental and behavioural changes: unusual mood change, aggression, hostility, personality or behavioural change, sudden anxiety or excitation, feeling confused✓
Allergic Reaction: difficulty swallowing or breathing, wheezing,✓

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
feeling sick to your stomach and throwing up, hives or rash, swelling of the face, lips, tongue or throat
UNKNOWN
Drug reaction with eosinophilia and systemic symptoms (DRESS) (serious skin reaction that may affect one or more organs): fever, severe rash, peeling skin, swelling of the face, swollen lymph glands, flu-like feeling, yellow skin or eyes, shortness of breath, dry cough, chest pain or discomfort, feel thirsty, urinating less often, less urine✓

If you/your child have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your/your child’s daily activities, tell your/their healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your/your child’s health professional if you/they need information about how to manage your/their side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store at room temperature (15ºC to 30 ºC).

Keep out of the reach and sight of children.

If you want more information about FYCOMPA:

  • Talk to your/your child’s healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website Eisai.ca, or by calling 1-877-873-4724.

FYCOMPA® is a registered trademark owned by Eisai R&D Management Co., Ltd.

Last revised: Nov 16, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02404516

Revision date stated in the text: November 16, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Fycompa

Rx or OTC
Prescription (Rx)?
DIN 02404516, 02404524, 02404532, 02404540, 02404559
Schedule(s) PRESCRIPTION
Active ingredient(s) Perampanel
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N03 Antiepileptics
      1. N03A Antiepileptics
        1. N03AX Other antiepileptics
          1. N03AX22 Perampanel
Company EISAI LIMITED
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02404516 2 MG Tablet Marketed June 19, 2013
02404524 4.0 MG Tablet Marketed June 19, 2013
02404532 6.0 MG Tablet Marketed June 19, 2013
02404540 8.0 MG Tablet Marketed June 19, 2013
02404559 10.0 MG Tablet Marketed June 3, 2013

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.